Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Searle uses Epimmune technologies to develop cancer therapies

March 4, 1998

Status of Oncolym updated

March 4, 1998

Select Therapeutics licenses cancer-related technology

March 3, 1998

Cell Pathways/U. of Arizona study compounds for precancerous lesions

March 3, 1998

Penclomedine metabolite shows comparable anticancer efficacy, reduced neurotoxicity

March 3, 1998

Takeda exercises option to develop therapeutic protein

March 3, 1998

New compound for mucositis in development at Alizyme

March 2, 1998

LXR and Copernicus establish cancer gene therapy collaboration

March 2, 1998

Bristol-Myers Squibb developing new paclitaxel derivatives

March 2, 1998

Improved treatment outlook for children with leukemia?

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...